Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference 

Rhea-AI Summary

Seer (Nasdaq: SEER) announced it will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston, MA. Seer’s management is scheduled to present on Wednesday, August 12 from 8:00 a.m. to 8:25 a.m. Eastern Time. A live webcast and archived replay will be available on the Investor section of the company’s website.

News Market Reaction – SEER

-1.34%

-1.34% Session close to close

In the Aug 4 session, SEER declined 1.34%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Seer’s current platform record shows low short positioning and net selling by insiders. The conferen...

Analysis

Seer’s current platform record shows low short positioning and net selling by insiders. The conference appearance supplies no operating result; subsequent disclosures would add measurable business information to assess.

Key Figures

Conference edition: 46th annual Presentation date: August 12, 2026 Presentation time: 8:00 a.m.–8:25 a.m. Eastern Time

3 metrics

Conference edition 46th annual Canaccord Genuity Growth Conference

Presentation date August 12, 2026 Scheduled management presentation

Presentation time 8:00 a.m.–8:25 a.m. Eastern Time Scheduled conference presentation

Historical Context

5 past events · Latest: Jul 28 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 28	acquisition proposal	Positive	+8.6%	Further improved proposal to acquire Seer coincided with a 8.63% 24-hour increase.
Jul 23	proxy solicitation	Negative	-3.9%	Activist group urged votes for nominees and against Seer’s tax benefit preservation plan.
Jul 20	proxy solicitation	Negative	-6.0%	Seer urged stockholders to support its director nominees on the BLUE proxy card.
Jul 20	acquisition rejection	Negative	-6.0%	Special committee rejected an unsolicited non-binding proposal offering $2.45 per share.
Jul 17	activist campaign	Positive	+0.5%	Radoff-JEC Group announced ISS support for its case for change at Seer.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Reactions varied: acquisition headlines produced both +8.63% and -5.99%, while proxy-related headlines produced -3.90% and +0.46%.

Key Terms

proteomic

1 terms

proteomic technical

"trusted partner for deep, unbiased proteomic insights"

Proteomic describes something related to the large-scale study of proteins—the working parts inside cells that carry out functions and signal changes. For investors, proteomic work can reveal new drug targets, diagnostic tests or biomarkers that change a company’s potential revenue and risk profile; think of it like analyzing all ingredients in a recipe to find which ones can be improved or swapped to make a better product.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Canaccord Genuity 46^th Annual Growth Conference in Boston, MA.

Seer’s management is scheduled to present on Wednesday, August 12^th from 8:00 a.m. to 8:25 a.m. Eastern Time / 5:00 a.m. to 5:25 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer's Proteograph Product Suite integrates proprietary engineered nanoparticles, automation instrumentation, optimized consumables, and advanced analytical software. Seer's products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.

Media Contact:
Patrick Schmidt
pr@seer.bio 

Investor Contact:
Marissa Bych
investor@seer.bio 

FAQ

When will Seer (NASDAQ: SEER) present at the Canaccord Genuity 46th Annual Growth Conference?

Seer will present on Wednesday, August 12, from 8:00 a.m. to 8:25 a.m. Eastern Time. According to Seer, this session is part of the Canaccord Genuity 46th Annual Growth Conference in Boston, offering investors scheduled management remarks.

What time is Seer’s Canaccord Genuity 46th Annual Growth Conference webcast for SEER stock investors?

The Seer presentation webcast runs from 8:00 a.m. to 8:25 a.m. Eastern Time. According to Seer, this corresponds to 5:00 a.m. to 5:25 a.m. Pacific Time, providing live virtual access for investors and interested stakeholders.

How can investors access the live webcast of Seer’s August 12, 2026 conference presentation?

Investors can access the live webcast on the Investor section of Seer’s website at investor.seer.bio. According to Seer, the session will be streamed in real time during the scheduled presentation window.

Will a replay of Seer’s Canaccord Genuity 46th Annual Growth Conference presentation be available?

Yes, an archived replay will be available on Seer’s website after the conference. According to Seer, investors who miss the live webcast can later access the recorded session through the company’s Investor section.

Where is the Canaccord Genuity 46th Annual Growth Conference featuring Seer’s presentation being held?

The conference featuring Seer’s presentation is being held in Boston, Massachusetts. According to Seer, while the physical event is in Boston, investors can follow the company’s presentation through the online webcast and subsequent replay.